At a glance
The April 5, 2021, Clinical Laboratory COVID-19 Response (CLCR) call included updates on SARS-CoV-2 variants and testing, and an FDA update.
Agenda
Archived LOCS Materials Access
Welcome: Nancy Anderson, CDC Division of Laboratory Systems (DLS)
Emergence of SARS-CoV-2 Variants and Impact on IVD Testing: Richard Creager, NIH RADx Variant Task Force
Saliva-Based SARS-CoV-2 Testing Data: Anne Wyllie, Yale University
FDA Update: Tim Stenzel, U.S. Food and Drug Administration (FDA)
This page was last updated on this date. Updates may include minor edits, image changes, or other modifications to page content.
The information on this page was last reviewed by subject matter experts to ensure accuracy.